참고문헌
- Larson RA. Etiology and management of therapy-related myeloid leukemia. Hematology Am Soc Hematol Educ Program 2007;2007:453-459. https://doi.org/10.1182/asheducation-2007.1.453
- Turker A, Guler N. Therapy related acute myeloid leukemia after exposure to 5-fluorouracil: a case report. Hematol Cell Ther 1999;41:195-196. https://doi.org/10.1007/s00282-999-0195-3
- Smith SM, Le Beau MM, Huo D, et al. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood 2003;102:43-52. https://doi.org/10.1182/blood-2002-11-3343
- Le Beau MM, Albain KS, Larson RA, et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol 1986;4:325-345. https://doi.org/10.1200/JCO.1986.4.3.325
- Yin CC, Cortes J, Barkoh B, Hayes K, Kantarjian H, Jones D. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy. Cancer 2006;106:1730-1738. https://doi.org/10.1002/cncr.21797
피인용 문헌
- Dietary polyphenols influence antimetabolite agents: methotrexate, 6-mercaptopurine and 5-fluorouracil in leukemia cell lines vol.8, pp.62, 2012, https://doi.org/10.18632/oncotarget.20501
- A Case of Therapy-related Acute Myeloid Leukemia Following Treatment with 5-Fluorouracil vol.10, pp.12, 2012, https://doi.org/10.7759/cureus.3769